Analyzing Orthofix Medical (OFIX) & Its Competitors

Orthofix Medical (NASDAQ:OFIX) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Orthofix Medical to similar businesses based on the strength of its dividends, profitability, earnings, institutional ownership, risk, valuation and analyst recommendations.

Profitability

This table compares Orthofix Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-5.39%	-10.32%	-5.19%
Orthofix Medical Competitors	-303.57%	-175.14%	-22.20%

Institutional & Insider Ownership

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Orthofix Medical and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Orthofix Medical	$822.31 million	-$92.19 million	-6.39
Orthofix Medical Competitors	$1.87 billion	$137.20 million	5.90

Orthofix Medical’s rivals have higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings and target prices for Orthofix Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1	1	3	0	2.40
Orthofix Medical Competitors	4295	10588	18373	832	2.46

Orthofix Medical presently has a consensus price target of $14.75, indicating a potential upside of 106.01%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.96%. Given Orthofix Medical’s higher possible upside, analysts plainly believe Orthofix Medical is more favorable than its rivals.

Volatility and Risk

Orthofix Medical has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Orthofix Medical’s rivals have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Summary

Orthofix Medical rivals beat Orthofix Medical on 7 of the 13 factors compared.

Orthofix Medical Company Profile

Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.